Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Villa

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Emerging Infectious Diseases|May 30, 2023
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, ItalyMartina Ferrari, Lorenza Di Marco, Alessandra Pivetti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2020
Influence of donor and recipient gender on liver transplantation outcomes in EuropeGiacomo Germani, Nicola Zeni, Alberto Zanetto, et al.
Infection|May 30, 2018
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosisAntonio Ascione, Massimo De Luca, Mario Melazzini, et al.
Cell Death & Disease|August 25, 2017
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical studyRosina Critelli, Fabiola Milosa, Francesca Faillaci, et al.
Disease Models & Mechanisms|July 18, 2015
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosisElena Turola, Salvatore Petta, Ester Vanni, et al.
Cancers|October 26, 2024
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization TreatmentRosina Maria Critelli, Federico Casari, Alberto Borghi, et al.
Cell Death and Differentiation|March 25, 2017
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2Daniela Gnani, Ilaria Romito, Simona Artuso, et al.
European Journal of Internal Medicine|July 4, 2020
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up studyStefano Gitto, Nicola De Maria, Luca Marzi, et al.
Hepatology (Baltimore, Md.)|June 26, 2015
Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1Lucía Barbier-Torres, Naiara Beraza, Pablo Fernández-Tussy, et al.
Advances in Therapy|May 11, 2022
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST StudyMarkus Cornberg, Adriana Ahumada, Alessio Aghemo, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Emerging Infectious Diseases|May 30, 2023
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, ItalyMartina Ferrari, Lorenza Di Marco, Alessandra Pivetti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2020
Influence of donor and recipient gender on liver transplantation outcomes in EuropeGiacomo Germani, Nicola Zeni, Alberto Zanetto, et al.
Infection|May 30, 2018
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosisAntonio Ascione, Massimo De Luca, Mario Melazzini, et al.
Cell Death & Disease|August 25, 2017
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical studyRosina Critelli, Fabiola Milosa, Francesca Faillaci, et al.
Disease Models & Mechanisms|July 18, 2015
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosisElena Turola, Salvatore Petta, Ester Vanni, et al.
Cancers|October 26, 2024
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization TreatmentRosina Maria Critelli, Federico Casari, Alberto Borghi, et al.
Cell Death and Differentiation|March 25, 2017
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2Daniela Gnani, Ilaria Romito, Simona Artuso, et al.
European Journal of Internal Medicine|July 4, 2020
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up studyStefano Gitto, Nicola De Maria, Luca Marzi, et al.
Hepatology (Baltimore, Md.)|June 26, 2015
Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1Lucía Barbier-Torres, Naiara Beraza, Pablo Fernández-Tussy, et al.
Advances in Therapy|May 11, 2022
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST StudyMarkus Cornberg, Adriana Ahumada, Alessio Aghemo, et al.
Pageof 15